Subscribe

Subscribe

Latest Content

Solar

Storage

Wind

Event Spotlight

BLOGS

DISTRIBUTECH+ RECAP: Energy Storage Utility Case Studies

Webcast

OPINION

RESOURCES

CLARION ENERGY MEDIA

POWER & ENERGY EVENT SERIES

Privacy Policy

Copyright © 2019 - 2021

Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nls Pharmaceutics Ltd (NQ: NLSP )

0.1740 -0.0145 (-7.69%)
Streaming Delayed Price Updated: 3:56 PM EDT, Aug 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 657,186
Open 0.1825
Bid (Size) 0.1700 (10)
Ask (Size) 0.1797 (45)
Prev. Close 0.1885
Today's Range 0.1726 - 0.1860
52wk Range 0.1112 - 1.205
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning! 
Via InvestorPlace
Dow Edges Lower; Ventyx Biosciences Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities

Performance

YTD
-70.40%
-70.40%
1 Month
-15.12%
-15.12%
3 Month
+19.18%
+19.18%
6 Month
-60.00%
-60.00%
1 Year
-79.14%
-79.14%

More News

Read More
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
NLS Pharmaceutics and Kadimastem Announce Binding Term Sheet to Merge
Via ACCESSWIRE
Why Is NLS Pharmaceutics (NLSP) Stock Up 163% Today?
Via InvestorPlace
Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump
Via Benzinga
Exposures Fossil Fuels
Tivic Health Systems (TIVC) Stock Pops Another 39%
Via InvestorPlace
Why Is NLS Pharmaceutics (NLSP) Stock Up 48% Today?
Via InvestorPlace
NLS Pharmaceutics Announces Registered Direct Offering
Via ACCESSWIRE
NLS Pharmaceutics Announces Promising Preclinical Results for Parkinson's Disease Treatments
Via ACCESSWIRE
Nasdaq Panel Grants NLS Pharmaceutics' Request for Extension to Comply with Continued Listing Requirements
Via ACCESSWIRE
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
PLTR Stock: Palantir Bags New Partnership With ARPA-H for AI/ML
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Dow Edges Lower; US Current Account Deficit Widens In Q1
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is NLS Pharmaceutics (NLSP) Stock Down 23% Today?
Via InvestorPlace
Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
US Stocks Mixed; Retail Sales Increase 0.1% In May
Via Benzinga
Why Is Quantum (QMCO) Stock Down 32% Today?
Via InvestorPlace
Why Is Aerwins Technologies (AWIN) Stock Down 54% Today?
Via InvestorPlace
Why Is Actelis Networks (ASNS) Stock Up 144% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why Chegg Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists (DOXA)
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.